Point72 Asset Management, L.P. 13D and 13G filings for Chinook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:12 pm Sale |
2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
Point72 Asset Management, L.P. | 1,299,548 2.000% |
-1,817,932 (-58.31%) |
Filing |
| 2022-06-07 4:45 pm Purchase |
2022-05-27 | 13G | Chinook Therapeutics, Inc. KDNY |
Point72 Asset Management, L.P. | 3,117,480 5.100% |
3,117,480 (New Position) |
Filing |